| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | 3.08e-05 | 430 | 18 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.62e-04 | 120 | 18 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.23e-04 | 654 | 18 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.29e-04 | 38 | 18 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 7.23e-04 | 200 | 18 | 3 | GO:0008237 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.13e-03 | 93 | 18 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.95e-03 | 749 | 18 | 4 | GO:0005509 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.59e-06 | 656 | 17 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.75e-06 | 658 | 17 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | microfibril | 4.83e-05 | 13 | 17 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | myosin complex | 1.04e-03 | 59 | 17 | 2 | GO:0016459 | |
| GeneOntologyCellularComponent | microvillus | 4.41e-03 | 123 | 17 | 2 | GO:0005902 | |
| Domain | PLAC | 2.72e-07 | 14 | 18 | 3 | PF08686 | |
| Domain | PLAC | 7.21e-07 | 19 | 18 | 3 | IPR010909 | |
| Domain | PLAC | 7.21e-07 | 19 | 18 | 3 | PS50900 | |
| Domain | ADAM_spacer1 | 1.32e-06 | 23 | 18 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.32e-06 | 23 | 18 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.50e-06 | 24 | 18 | 3 | IPR013273 | |
| Domain | Peptidase_M12B_N | 6.72e-06 | 39 | 18 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.72e-06 | 39 | 18 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.26e-06 | 40 | 18 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 7.26e-06 | 40 | 18 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.26e-06 | 40 | 18 | 3 | PS50214 | |
| Domain | Reprolysin | 7.26e-06 | 40 | 18 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 7.26e-06 | 40 | 18 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 7.83e-06 | 41 | 18 | 3 | IPR001762 | |
| Domain | TSP_1 | 2.88e-05 | 63 | 18 | 3 | PF00090 | |
| Domain | MYTH4 | 3.15e-05 | 9 | 18 | 2 | PS51016 | |
| Domain | MyTH4_dom | 3.15e-05 | 9 | 18 | 2 | IPR000857 | |
| Domain | MyTH4 | 3.15e-05 | 9 | 18 | 2 | SM00139 | |
| Domain | MyTH4 | 3.15e-05 | 9 | 18 | 2 | PF00784 | |
| Domain | TSP1 | 3.16e-05 | 65 | 18 | 3 | SM00209 | |
| Domain | TSP1_rpt | 3.16e-05 | 65 | 18 | 3 | IPR000884 | |
| Domain | TSP1 | 3.16e-05 | 65 | 18 | 3 | PS50092 | |
| Domain | MetalloPept_cat_dom | 6.12e-05 | 81 | 18 | 3 | IPR024079 | |
| Domain | - | 6.12e-05 | 81 | 18 | 3 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.08e-04 | 98 | 18 | 3 | PS00142 | |
| Domain | MYOSIN_MOTOR | 6.04e-04 | 38 | 18 | 2 | PS51456 | |
| Domain | Myosin_head | 6.04e-04 | 38 | 18 | 2 | PF00063 | |
| Domain | Myosin_head_motor_dom | 6.04e-04 | 38 | 18 | 2 | IPR001609 | |
| Domain | MYSc | 6.04e-04 | 38 | 18 | 2 | SM00242 | |
| Domain | FERM_M | 8.85e-04 | 46 | 18 | 2 | PF00373 | |
| Domain | FERM_central | 1.00e-03 | 49 | 18 | 2 | IPR019748 | |
| Domain | FERM_domain | 1.00e-03 | 49 | 18 | 2 | IPR000299 | |
| Domain | - | 1.00e-03 | 49 | 18 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 1.05e-03 | 50 | 18 | 2 | PS00660 | |
| Domain | FERM_2 | 1.05e-03 | 50 | 18 | 2 | PS00661 | |
| Domain | Band_41_domain | 1.05e-03 | 50 | 18 | 2 | IPR019749 | |
| Domain | B41 | 1.05e-03 | 50 | 18 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.05e-03 | 50 | 18 | 2 | IPR014352 | |
| Domain | FERM_3 | 1.05e-03 | 50 | 18 | 2 | PS50057 | |
| Domain | IQ | 2.10e-03 | 71 | 18 | 2 | PF00612 | |
| Domain | ZF_RING_1 | 2.57e-03 | 291 | 18 | 3 | PS00518 | |
| Domain | IQ | 2.72e-03 | 81 | 18 | 2 | SM00015 | |
| Domain | ZF_RING_2 | 2.75e-03 | 298 | 18 | 3 | PS50089 | |
| Domain | RING | 2.93e-03 | 305 | 18 | 3 | SM00184 | |
| Domain | EGF_CA | 3.06e-03 | 86 | 18 | 2 | PF07645 | |
| Domain | IQ_motif_EF-hand-BS | 3.34e-03 | 90 | 18 | 2 | IPR000048 | |
| Domain | Znf_RING | 3.54e-03 | 326 | 18 | 3 | IPR001841 | |
| Domain | IQ | 3.56e-03 | 93 | 18 | 2 | PS50096 | |
| Domain | EGF_Ca-bd_CS | 3.87e-03 | 97 | 18 | 2 | IPR018097 | |
| Domain | EGF_CA | 4.03e-03 | 99 | 18 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.11e-03 | 100 | 18 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.60e-03 | 106 | 18 | 2 | IPR000152 | |
| Domain | EGF_CA | 6.05e-03 | 122 | 18 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.24e-03 | 124 | 18 | 2 | IPR001881 | |
| Domain | EGF | 6.44e-03 | 126 | 18 | 2 | PF00008 | |
| Domain | - | 8.61e-03 | 449 | 18 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 9.14e-03 | 459 | 18 | 3 | IPR013083 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.78e-07 | 68 | 14 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.19e-06 | 109 | 14 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.43e-06 | 111 | 14 | 4 | M27416 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.98e-06 | 39 | 14 | 3 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.98e-06 | 39 | 14 | 3 | M27417 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.39e-06 | 143 | 14 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.40e-05 | 250 | 14 | 4 | M27554 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 9.45e-08 | 18 | 18 | 3 | 35503090 | |
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 2.53e-07 | 2 | 18 | 2 | 27779234 | |
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 2.53e-07 | 2 | 18 | 2 | 11941487 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 19836009 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 36810712 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 20301293 | ||
| Pubmed | Genome-wide association study identifies two susceptibility loci for osteosarcoma. | 2.53e-06 | 5 | 18 | 2 | 23727862 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 11212352 | ||
| Pubmed | 7.68e-06 | 75 | 18 | 3 | 20637190 | ||
| Pubmed | 1.14e-05 | 10 | 18 | 2 | 11167130 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.66e-05 | 12 | 18 | 2 | 25770910 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 8022818 | ||
| Pubmed | 2.32e-05 | 1215 | 18 | 6 | 15146197 | ||
| Pubmed | Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea. | 4.30e-05 | 19 | 18 | 2 | 34124068 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.95e-04 | 1105 | 18 | 5 | 35748872 | |
| Pubmed | 2.80e-04 | 638 | 18 | 4 | 31182584 | ||
| Pubmed | 2.81e-04 | 48 | 18 | 2 | 8884266 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.18e-02 | 423 | 18 | 2 | chr12q13 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.80e-07 | 19 | 13 | 3 | 50 | |
| GeneFamily | A-kinase anchoring proteins|Myosins, class VII|Deafness associated genes|FERM domain containing | 4.77e-07 | 2 | 13 | 2 | 1102 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.73e-04 | 50 | 13 | 2 | 1293 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN | 2.14e-04 | 173 | 18 | 3 | M2953 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN | 2.77e-04 | 36 | 18 | 2 | M13327 | |
| Coexpression | GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP | 2.82e-04 | 190 | 18 | 3 | M3282 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN | 3.14e-04 | 197 | 18 | 3 | M8338 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 3.19e-04 | 198 | 18 | 3 | M5701 | |
| Coexpression | GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 3.23e-04 | 199 | 18 | 3 | M9252 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 3.23e-04 | 199 | 18 | 3 | M7190 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN | 3.28e-04 | 200 | 18 | 3 | M7186 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 3.28e-04 | 200 | 18 | 3 | M5679 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 3.28e-04 | 200 | 18 | 3 | M8997 | |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_DN | 3.28e-04 | 200 | 18 | 3 | M4798 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 160 | 18 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 160 | 18 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-05 | 160 | 18 | 3 | 903727c14e370e5705394240f0ef61fe3e0a4c25 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 166 | 18 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 169 | 18 | 3 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 170 | 18 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 176 | 18 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 4.76e-05 | 178 | 18 | 3 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-05 | 182 | 18 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 184 | 18 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 184 | 18 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 184 | 18 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-05 | 185 | 18 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-05 | 191 | 18 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.14e-05 | 194 | 18 | 3 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 194 | 18 | 3 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 194 | 18 | 3 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-05 | 196 | 18 | 3 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.43e-05 | 197 | 18 | 3 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.52e-05 | 198 | 18 | 3 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-05 | 199 | 18 | 3 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-05 | 199 | 18 | 3 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-05 | 199 | 18 | 3 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 200 | 18 | 3 | 8a2c6c53a39fab86750526083f7254b7413b29af | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 200 | 18 | 3 | c32ad15dede3f879007c0b856f2fed1f5b058103 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 9f21e4e0913d8ef95a3f771dff0abaad8fe1d9f2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 0ff2607c58bc929e203f407ecf3605e0b21bfa90 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | de23a5d22d94935802b5b84a9e029b3f62c57028 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-04 | 71 | 18 | 2 | 5d63a582229520b2a037f3c27f772e34cdee092b | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.42e-04 | 86 | 18 | 2 | db67c05c876a5649371c0dc6c941cc371bc2feb8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.42e-04 | 86 | 18 | 2 | 2778446e035c5585bce28ed0ef93b87b6ad90c6e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.83e-04 | 110 | 18 | 2 | ee45592e936d32881c0f3429c21360670e5b3ce3 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.83e-04 | 110 | 18 | 2 | b9c8014fd2820e5ea28a7e02fd24227b99e71eb3 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.05e-03 | 120 | 18 | 2 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-03 | 125 | 18 | 2 | e112787b05d8147093357c9861877f6620b9e271 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-03 | 125 | 18 | 2 | 34d5be868c9728cc4f9ce0d65acf0e50171d2587 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.17e-03 | 127 | 18 | 2 | df2854bcb2708ddc13b3ca48c03887380e827790 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-03 | 132 | 18 | 2 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-03 | 134 | 18 | 2 | bffd6ce8998368d4f486b64c220eab3a44ba147b | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 136 | 18 | 2 | a2063abe2d7c3277bfbe1514c8c66363cf04b248 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B0|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 137 | 18 | 2 | fec21e7a25241289b18aea6a46dc2b981438ebe6 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 137 | 18 | 2 | 8e2fa2ef8becace96a68bb85c002329110902fbb | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.46e-03 | 142 | 18 | 2 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.46e-03 | 142 | 18 | 2 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.46e-03 | 142 | 18 | 2 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 148 | 18 | 2 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-03 | 148 | 18 | 2 | c240d506151fa90c59f40008c5fb31984c6f6f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 150 | 18 | 2 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-03 | 151 | 18 | 2 | 3b4c57bad61e17a573e6f8dc6b917fba5fd56c43 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-03 | 151 | 18 | 2 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-03 | 152 | 18 | 2 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 152 | 18 | 2 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 152 | 18 | 2 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-03 | 155 | 18 | 2 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.81e-03 | 158 | 18 | 2 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 159 | 18 | 2 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.83e-03 | 159 | 18 | 2 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 159 | 18 | 2 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.85e-03 | 160 | 18 | 2 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-03 | 161 | 18 | 2 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.88e-03 | 161 | 18 | 2 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.88e-03 | 161 | 18 | 2 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-03 | 161 | 18 | 2 | 20ac00dcdab2926b6e68862e1714fc68a032844b | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 1.88e-03 | 161 | 18 | 2 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-03 | 162 | 18 | 2 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-03 | 162 | 18 | 2 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-03 | 162 | 18 | 2 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-03 | 163 | 18 | 2 | 7352c30c253f69f65dcb15f46f9c87719741b55b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-03 | 163 | 18 | 2 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.92e-03 | 163 | 18 | 2 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-03 | 164 | 18 | 2 | 69b6566fb88c7449b7ab9056b57508cb6a1aa2af | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-03 | 164 | 18 | 2 | ed7e0c8ccad7d19b9cc72d70391936ff5e698f28 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-03 | 164 | 18 | 2 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-03 | 165 | 18 | 2 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 165 | 18 | 2 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-03 | 166 | 18 | 2 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-03 | 166 | 18 | 2 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-03 | 166 | 18 | 2 | 2e8ac5e84b2231d7405121f1681623b25d1ec3ca | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-03 | 166 | 18 | 2 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-03 | 166 | 18 | 2 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 1.99e-03 | 166 | 18 | 2 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.02e-03 | 167 | 18 | 2 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.02e-03 | 167 | 18 | 2 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_CCDC184|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-03 | 167 | 18 | 2 | ef3ef83c213e818597600da15764c5b37763d7b6 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 167 | 18 | 2 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-03 | 167 | 18 | 2 | fa5184441446fde6c7eaaf91aad038cf045dde65 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 167 | 18 | 2 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 167 | 18 | 2 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 167 | 18 | 2 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 167 | 18 | 2 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-03 | 168 | 18 | 2 | 60f91560eedf37468c51e4fd0c34fa5e8207dee4 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.04e-03 | 168 | 18 | 2 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | 1.48e-05 | 196 | 18 | 4 | 4204_DN | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.57e-05 | 199 | 18 | 4 | 3784_UP | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 9.37e-07 | 3 | 17 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 1.87e-06 | 4 | 17 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.87e-06 | 4 | 17 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | osteosarcoma | 8.73e-06 | 8 | 17 | 2 | EFO_0000637 | |
| Disease | vital capacity | 4.44e-05 | 1236 | 17 | 6 | EFO_0004312 | |
| Disease | exercise test | 5.90e-05 | 20 | 17 | 2 | EFO_0004328 | |
| Disease | carpal tunnel syndrome | 1.19e-03 | 89 | 17 | 2 | EFO_0004143 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.00e-03 | 447 | 17 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | peak expiratory flow | 2.72e-03 | 498 | 17 | 3 | EFO_0009718 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCNEVFCFKCRQMYH | 251 | O95376 | |
| FCFKCRQMYHAPTDC | 256 | O95376 | |
| AFNVTRKMCCCSYNI | 1666 | Q75N90 | |
| FCSRAYFRQMCCKTC | 1086 | Q9H324 | |
| CCQTCRDFYANKMRQ | 1076 | Q8TE56 | |
| CSRAYFRQMCCKTCQ | 1101 | Q9UKP5 | |
| FNMCFNYNVRVLCCD | 1866 | Q9HC84 | |
| FKMCFNYEIRVFCCN | 2396 | Q9HC84 | |
| KMCFNYEIRVFCCNY | 4211 | Q9HC84 | |
| RCQYCRLQKCFEVGM | 141 | P13631 | |
| YFQFNKMDHSCRACE | 1206 | Q9ULI3 | |
| CCFQHRRCYEEAAEM | 116 | Q02509 | |
| CFQKYSCCCHLMEIF | 386 | P51878 | |
| IECMGRNFHENCYRC | 321 | Q8WUP2 | |
| YCQMRCTFHPRCLLF | 46 | P03952 | |
| KMVANCCRFLCYFCR | 2191 | Q92736 | |
| CYFCRISRQNQKAMF | 2201 | Q92736 | |
| HIFKYLNIQACCRMD | 296 | Q5VUJ6 | |
| RISCCQYCKIEFHMN | 676 | P53804 | |
| NVYHFACAIRAKCMF | 5111 | O14686 | |
| CYFNMKRNSRDQCCI | 141 | Q13402 | |
| CYFSMKRNKRDQCCI | 141 | Q6PIF6 |